Brief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
14/04/2026 02:21
April 14 (Reuters) - Clarity Pharmaceuticals Ltd CU6.AX: SIGNS COMMERCIAL MANUFACTURING AGREEMENT COMMERCIAL MANUFACTURING AGREEMENT FOR CU-64 SAR-BISPSMA WITH NUCLEUS RADIOPHARMA Further company coverage: CU6.AX ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clarity Pharmaceuticals
See all newsBrief: Clarity Pharmaceuticals Signs Commercial Manufacturing Agreement
Brief: Clarity Signs A Large-Scale Manufacturing Supply Agreement For Copper-64 With Theragenics
Brief: Clarity Pharmaceuticals Signs A Large-Scale Manufacturing Supply Agreement
Australia's Clarity Pharmaceuticals rises on bagging cancer detection agent supply
Australia's Clarity Pharma surges as US FDA approves trial